Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Michael Angarone"'
Autor:
Kendall Kling, Rebecca Osborn, Adil Menon, Janna Williams, Ryan Cardew, Omar Al-Heeti, Phillip Santoiemma, Michael Angarone, Samuel Gatesy, Travis Kochan, Teresa Zembower, Karen Krueger, Egon A. Ozer, Chao Qi
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 33, Iss , Pp 100397- (2023)
Mycobacterium xenopi is a slow growing non-tuberculous mycobacterium (NTM) isolated from water systems and has been associated with pseudo-outbreaks and pulmonary infections in humans. We observed a cluster of six respiratory cultures positive for M.
Externí odkaz:
https://doaj.org/article/e411352e07e141569941ecdfd5fe662c
Publikováno v:
Infectious Diseases in Clinical Practice. 31
Autor:
Omar Al-Heeti, Rebecca N. Kumar, Kendall Kling, Michael Angarone, Chad Achenbach, Babafemi Taiwo
Publikováno v:
Journal of Antimicrobial Chemotherapy. 77:854-856
Autor:
Brad, Spellberg, Gloria, Aggrey, Meghan B, Brennan, Brent, Footer, Graeme, Forrest, Fergus, Hamilton, Emi, Minejima, Jessica, Moore, Jaimo, Ahn, Michael, Angarone, Robert M, Centor, Kartikeya, Cherabuddi, Jennifer, Curran, Kusha, Davar, Joshua, Davis, Mei Qin, Dong, Bassam, Ghanem, Doug, Hutcheon, Philipp, Jent, Minji, Kang, Rachael, Lee, Emily G, McDonald, Andrew M, Morris, Rebecca, Reece, Ilan S, Schwartz, Miranda, So, Steven, Tong, Christopher, Tucker, Noah, Wald-Dickler, Erica J, Weinstein, Riley, Williams, Christina, Yen, Shiwei, Zhou, Todd C, Lee, Dominique, Werge
Publikováno v:
Spellberg, Brad; Aggrey, Gloria; Brennan, Meghan B; Footer, Brent; Forrest, Graeme; Hamilton, Fergus; Minejima, Emi; Moore, Jessica; Ahn, Jaimo; Angarone, Michael; Centor, Robert M; Cherabuddi, Kartikeya; Curran, Jennifer; Davar, Kusha; Davis, Joshua; Dong, Mei Qin; Ghanem, Bassam; Hutcheon, Doug; Jent, Philipp; Kang, Minji; ... (2022). Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults: A WikiGuidelines Group Consensus Statement. JAMA Network Open, 5(5), e2211321. American Medical Association 10.1001/jamanetworkopen.2022.11321
2022, ' Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults : A WikiGuidelines Group Consensus Statement ', JAMA Network Open, vol. 5, no. 5, pp. e2211321 . https://doi.org/10.1001/jamanetworkopen.2022.11321
2022, ' Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults : A WikiGuidelines Group Consensus Statement ', JAMA Network Open, vol. 5, no. 5, pp. e2211321 . https://doi.org/10.1001/jamanetworkopen.2022.11321
Importance: Traditional approaches to practice guidelines frequently result in dissociation between strength of recommendation and quality of evidence.Objective: To construct a clinical guideline for pyogenic osteomyelitis management, with a new stan
Autor:
Valentina Stosor, Michael Angarone
Publikováno v:
The Journal of Infectious Diseases. 224:1275-1277
Publikováno v:
The American Journal of Medicine. 133:186-190
Publikováno v:
Transplant Infectious Disease
Autor:
Michael Angarone, Amanda J. Krause
Publikováno v:
Infectious Diseases in Clinical Practice. 29:e44-e46
Autor:
Uyen To, Michael Angarone, Anahita Rabiee, Marcela Laurito, Phillip P. Santoiemma, Lamia Haque, Saad Saffo, Guadalupe Garcia-Tsao, Elizabeth C. Verna
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 20(5)
Spontaneous bacterial peritonitis (SBP) is a feared complication of ascites that affects 10%-30% of hospitalized patients with cirrhosis with an associated mortality rate of approximately 20%.1-3 Although efforts have been undertaken to encourage pro
Autor:
Valentina Stosor, William Justin Moore, Michael Angarone, Chad J. Achenbach, Rebecca N. Kumar, Michael G. Ison, En-Ling Wu
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background Coronavirus disease 2019 (COVID-19) has strained healthcare systems with patient hospitalizations and deaths. Anti-spike monoclonal antibodies, including bamlanivimab, have demonstrated reduction in hospitalization rates in clinical trials